Global Health Valuation
| MEDANTA Stock | 1,076 0.20 0.02% |
At this time, the firm appears to be overvalued. Global Health Limited retains a regular Real Value of USD964.09 per share. The prevalent price of the firm is USD1076.35. Our model calculates the value of Global Health Limited from evaluating the firm fundamentals such as Return On Equity of 0.18, return on asset of 0.093, and Current Valuation of 285.86 B as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 9.2028 | Enterprise Value 285.9 B | Enterprise Value Ebitda 31.9687 | Price Sales 8.5966 | Trailing PE 59.0599 |
Overvalued
Today
Please note that Global Health's price fluctuation is very steady at this time. Calculation of the real value of Global Health Limited is based on 3 months time horizon. Increasing Global Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Global Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Global Stock. However, Global Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1076.35 | Real 964.09 | Hype 1077.01 | Naive 1110.43 |
The real value of Global Stock, also known as its intrinsic value, is the underlying worth of Global Health Limited Company, which is reflected in its stock price. It is based on Global Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Global Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Global Health Limited helps investors to forecast how Global stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Global Health more accurately as focusing exclusively on Global Health's fundamentals will not take into account other important factors: Global Health Cash |
|
Global Health Total Value Analysis
Global Health Limited is now estimated to have takeover price of 285.86 B with market capitalization of 288.55 B, debt of 8.02 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Global Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
285.86 B | 288.55 B | 8.02 B |
Global Health Investor Information
About 68.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 18.19. Global Health Limited had not issued any dividends in recent years. Based on the key indicators obtained from Global Health's historical financial statements, Global Health Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 3.9 B | 6.1 B |
|
| |||||
| Operating Income | 12.3 B | 11.7 B |
|
|
Global Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Global Health has an asset utilization ratio of 76.09 percent. This suggests that the Company is making USD0.76 for each dollar of assets. An increasing asset utilization means that Global Health Limited is more efficient with each dollar of assets it utilizes for everyday operations.Global Health Ownership Allocation
Global Health Limited has a total of 268.55 Million outstanding shares. Global Health retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.06 (percent) of Global Health outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Global Health Profitability Analysis
The company reported the revenue of 32.75 B. Net Income was 4.78 B with profit before overhead, payroll, taxes, and interest of 13.74 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Global Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Global Health and how it compares across the competition.
About Global Health Valuation
The stock valuation mechanism determines Global Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Global Health. We calculate exposure to Global Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Global Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 17.2 B | 13 B |
Global Health Quarterly Retained Earnings |
|
Complementary Tools for Global Stock analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |